These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3033616

  • 1. High affinity binding of cholecystokinin to small cell lung cancer cells.
    Yoder DG, Moody TW.
    Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
    [Abstract] [Full Text] [Related]

  • 2. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 3. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors.
    Huang SC, Yu DH, Wank SA, Mantey S, Gardner JD, Jensen RT.
    Peptides; 1989 Mar; 10(4):785-9. PubMed ID: 2479932
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.
    Cross AJ, Slater P, Skan W.
    Neuropeptides; 1988 Mar; 11(2):73-6. PubMed ID: 3368039
    [Abstract] [Full Text] [Related]

  • 5. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
    Reubi JC, Schaer JC, Waser B.
    Cancer Res; 1997 Apr 01; 57(7):1377-86. PubMed ID: 9102227
    [Abstract] [Full Text] [Related]

  • 7. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 8. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U, Harhammer R, Boomgaarden M, Sohr R, Ott T, Henklein P, Repke H.
    J Neurochem; 1994 Apr 01; 62(4):1426-31. PubMed ID: 8133271
    [Abstract] [Full Text] [Related]

  • 9. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
    Jansen JB, Lamers CB.
    J Immunol Methods; 1984 Jun 08; 71(1):1-8. PubMed ID: 6539353
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of a new labeled gastrin ligand, 125-I-BH-[Leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells.
    Galleyrand JC, Lima-Leite AC, Lallement JC, Lignon MF, Bernad N, Fulcrand P, Martinez J.
    Int J Pept Protein Res; 1994 Oct 08; 44(4):348-56. PubMed ID: 7875937
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH, Huang SC, Wank SA, Mantey S, Gardner JD, Jensen RT.
    Am J Physiol; 1990 Jan 08; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [Abstract] [Full Text] [Related]

  • 12. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
    Staley J, Jensen RT, Moody TW.
    Peptides; 1990 Jan 08; 11(5):1033-6. PubMed ID: 2178246
    [Abstract] [Full Text] [Related]

  • 13. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S, Wank SA.
    J Biol Chem; 1996 Jun 21; 271(25):14698-706. PubMed ID: 8663021
    [Abstract] [Full Text] [Related]

  • 14. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec 21; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP, Zhou W, Longnecker DS, Bell RH.
    Oncol Res; 1994 Dec 21; 6(9):411-7. PubMed ID: 7703527
    [Abstract] [Full Text] [Related]

  • 16. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 21; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 17. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
    Lallement JC, Oiry C, Lima-Leite AC, Lignon MF, Fulcrand P, Galleyrand JC, Martinez J.
    Eur J Pharmacol; 1995 Jul 18; 290(2):61-7. PubMed ID: 8575534
    [Abstract] [Full Text] [Related]

  • 18. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
    Lallement JC, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.
    Eur J Pharmacol; 1994 May 17; 267(3):297-305. PubMed ID: 8088368
    [Abstract] [Full Text] [Related]

  • 19. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW, Miller T.
    J Pharmacol Exp Ther; 1985 Mar 17; 232(3):775-80. PubMed ID: 2983069
    [Abstract] [Full Text] [Related]

  • 20. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site.
    Clark CR, Daum P, Hughes J.
    J Neurochem; 1986 Apr 17; 46(4):1094-101. PubMed ID: 3005503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.